Clinical utility of one month imaging following selective internal radiation therapy

Research output: Contribution to journalArticle

Abstract

Purpose: The goal of this retrospective review was to determine the clinical relevance of one-month post-treatment imaging in the selective internal radiation therapy (SIRT) patient population by reporting the incidence of change in clinical management. Materials and methods: Between January 2012 and January 2016, 85 patients underwent 109 SIRT treatments for either primary or secondary hepatic malignancies. There were 59 men and 26 women with a mean age of 62.4 years (range: 39–89 years). Patients’ medical records were retrospectively reviewed for procedural, historical, laboratory and imaging information. The imaging study was considered to have changed patients’ clinical management if it resulted in the addition of a new procedure, canceling of a planned procedure or change in systemic therapy. Results: The one-month post-treatment imaging findings led to management changes in 10 of 109 (9.2%) of treatments. When evaluated by cancer type, 2/61 (3.3%) hepatocellular carcinoma (HCC) treatments had management changed while 8/48 (16.7%) non-HCC treatments underwent management change (P = 0.03). This difference was also significant at multivariate analysis (P = 0.03; odds ratio: 0.17 [0.03–082]). Conclusion: Management is rarely changed by one-month post-SIRT imaging in patients with HCC and thus is likely unwarranted. Conversely, in non-HCC patients, one month post-SIRT imaging led to a significant percentage of clinical management changes suggesting that one month imaging in this setting is likely warranted.

Original languageEnglish (US)
Pages (from-to)39-46
Number of pages8
JournalDiagnostic and Interventional Imaging
Volume100
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Radiotherapy
Therapeutics
Hepatocellular Carcinoma
Carcinoma
Medical Records
Neoplasms
Multivariate Analysis
Odds Ratio
Liver
Incidence
Population

Keywords

  • Hepatocellular carcinoma
  • Metastatic liver disease
  • Selective internal radiation therapy (SIRT)
  • Transarterial radioembolization
  • Treatment strategy

PubMed: MeSH publication types

  • Journal Article

Cite this

Clinical utility of one month imaging following selective internal radiation therapy. / Young, Shamar J; Taylor, A.; Golzarian, Jafar; Flanagan, Siobhan M; D'Souza, Donna L; Sanghvi, Tina S.

In: Diagnostic and Interventional Imaging, Vol. 100, No. 1, 01.01.2019, p. 39-46.

Research output: Contribution to journalArticle

@article{b666e1ced8254bf9804bb87b8d57bc21,
title = "Clinical utility of one month imaging following selective internal radiation therapy",
abstract = "Purpose: The goal of this retrospective review was to determine the clinical relevance of one-month post-treatment imaging in the selective internal radiation therapy (SIRT) patient population by reporting the incidence of change in clinical management. Materials and methods: Between January 2012 and January 2016, 85 patients underwent 109 SIRT treatments for either primary or secondary hepatic malignancies. There were 59 men and 26 women with a mean age of 62.4 years (range: 39–89 years). Patients’ medical records were retrospectively reviewed for procedural, historical, laboratory and imaging information. The imaging study was considered to have changed patients’ clinical management if it resulted in the addition of a new procedure, canceling of a planned procedure or change in systemic therapy. Results: The one-month post-treatment imaging findings led to management changes in 10 of 109 (9.2{\%}) of treatments. When evaluated by cancer type, 2/61 (3.3{\%}) hepatocellular carcinoma (HCC) treatments had management changed while 8/48 (16.7{\%}) non-HCC treatments underwent management change (P = 0.03). This difference was also significant at multivariate analysis (P = 0.03; odds ratio: 0.17 [0.03–082]). Conclusion: Management is rarely changed by one-month post-SIRT imaging in patients with HCC and thus is likely unwarranted. Conversely, in non-HCC patients, one month post-SIRT imaging led to a significant percentage of clinical management changes suggesting that one month imaging in this setting is likely warranted.",
keywords = "Hepatocellular carcinoma, Metastatic liver disease, Selective internal radiation therapy (SIRT), Transarterial radioembolization, Treatment strategy",
author = "Young, {Shamar J} and A. Taylor and Jafar Golzarian and Flanagan, {Siobhan M} and D'Souza, {Donna L} and Sanghvi, {Tina S}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.diii.2018.07.005",
language = "English (US)",
volume = "100",
pages = "39--46",
journal = "Diagnostic and interventional imaging",
issn = "2211-5684",
publisher = "Elsevier Masson",
number = "1",

}

TY - JOUR

T1 - Clinical utility of one month imaging following selective internal radiation therapy

AU - Young, Shamar J

AU - Taylor, A.

AU - Golzarian, Jafar

AU - Flanagan, Siobhan M

AU - D'Souza, Donna L

AU - Sanghvi, Tina S

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: The goal of this retrospective review was to determine the clinical relevance of one-month post-treatment imaging in the selective internal radiation therapy (SIRT) patient population by reporting the incidence of change in clinical management. Materials and methods: Between January 2012 and January 2016, 85 patients underwent 109 SIRT treatments for either primary or secondary hepatic malignancies. There were 59 men and 26 women with a mean age of 62.4 years (range: 39–89 years). Patients’ medical records were retrospectively reviewed for procedural, historical, laboratory and imaging information. The imaging study was considered to have changed patients’ clinical management if it resulted in the addition of a new procedure, canceling of a planned procedure or change in systemic therapy. Results: The one-month post-treatment imaging findings led to management changes in 10 of 109 (9.2%) of treatments. When evaluated by cancer type, 2/61 (3.3%) hepatocellular carcinoma (HCC) treatments had management changed while 8/48 (16.7%) non-HCC treatments underwent management change (P = 0.03). This difference was also significant at multivariate analysis (P = 0.03; odds ratio: 0.17 [0.03–082]). Conclusion: Management is rarely changed by one-month post-SIRT imaging in patients with HCC and thus is likely unwarranted. Conversely, in non-HCC patients, one month post-SIRT imaging led to a significant percentage of clinical management changes suggesting that one month imaging in this setting is likely warranted.

AB - Purpose: The goal of this retrospective review was to determine the clinical relevance of one-month post-treatment imaging in the selective internal radiation therapy (SIRT) patient population by reporting the incidence of change in clinical management. Materials and methods: Between January 2012 and January 2016, 85 patients underwent 109 SIRT treatments for either primary or secondary hepatic malignancies. There were 59 men and 26 women with a mean age of 62.4 years (range: 39–89 years). Patients’ medical records were retrospectively reviewed for procedural, historical, laboratory and imaging information. The imaging study was considered to have changed patients’ clinical management if it resulted in the addition of a new procedure, canceling of a planned procedure or change in systemic therapy. Results: The one-month post-treatment imaging findings led to management changes in 10 of 109 (9.2%) of treatments. When evaluated by cancer type, 2/61 (3.3%) hepatocellular carcinoma (HCC) treatments had management changed while 8/48 (16.7%) non-HCC treatments underwent management change (P = 0.03). This difference was also significant at multivariate analysis (P = 0.03; odds ratio: 0.17 [0.03–082]). Conclusion: Management is rarely changed by one-month post-SIRT imaging in patients with HCC and thus is likely unwarranted. Conversely, in non-HCC patients, one month post-SIRT imaging led to a significant percentage of clinical management changes suggesting that one month imaging in this setting is likely warranted.

KW - Hepatocellular carcinoma

KW - Metastatic liver disease

KW - Selective internal radiation therapy (SIRT)

KW - Transarterial radioembolization

KW - Treatment strategy

UR - http://www.scopus.com/inward/record.url?scp=85050864714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050864714&partnerID=8YFLogxK

U2 - 10.1016/j.diii.2018.07.005

DO - 10.1016/j.diii.2018.07.005

M3 - Article

C2 - 30082184

AN - SCOPUS:85050864714

VL - 100

SP - 39

EP - 46

JO - Diagnostic and interventional imaging

JF - Diagnostic and interventional imaging

SN - 2211-5684

IS - 1

ER -